MX9604430A - Tiazolidinas del tipo piridina. - Google Patents

Tiazolidinas del tipo piridina.

Info

Publication number
MX9604430A
MX9604430A MX9604430A MX9604430A MX9604430A MX 9604430 A MX9604430 A MX 9604430A MX 9604430 A MX9604430 A MX 9604430A MX 9604430 A MX9604430 A MX 9604430A MX 9604430 A MX9604430 A MX 9604430A
Authority
MX
Mexico
Prior art keywords
group
alkyl
cycloalkyl
thiazolidines
substituted
Prior art date
Application number
MX9604430A
Other languages
English (en)
Inventor
Yoshio Ohara
Mikio Suzuki
Nobuhide Miyachi
Katsuhiro Kato
Keisuke Ohdoi
Tetsuya Kobayashi
Ken-Ichi Shikada
Takeshi Naito
Takashi Yotsumoto
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of MX9604430A publication Critical patent/MX9604430A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invencion provee tiazolidinas del tipo piridina, novedosas y sus sales, expresadas pro la siguiente formula (I): (Ver Formula) (en donde X1 es 5 u 0; X2 es 5, O o NH; Y es CR6R7 (R6 es un átomo de hidrogeno, un grupo alquilo de 1 a 7 átomos de carbono o un grupo cicloalqulo de 3 a 7 átomos de carbono; y R7 es un átomo de hidrogeno, un grupo alquilo de 1 a 7 átomos de carbono o un grupo cicloaqluilo de 3 a 7 átomos de carbono; o juntos forman una ligadura con R4), o SO2, Z es un grupo alquilo de 1 a 10 átomos de carbono, un grupo alquenilo de 2 a 10 átomos de carbono, un grupo alquenilo de 2 a 10átomos de carbono, un grupo cicloalquilo de 3 a 7 átomos de carbono, un grupo cicloalquenilo de 3 a 7 átomos de carbono (cada uno de los grupos alquilo, alquenilo, alquinilo, cicloalquilo y cicloaquenilo puede estar sustituido con a lo sumo tres grupos hidroxilo, oxo alquilo de 1 a 7 átomos de carbono y alcoxi de 1 a 7 átomos de carbono); un grupo fenilo, un grupo bifenilo, un grupo alfa-naftilo, un grupo beta-naftilo, un grupo bencilo, un grupo piridilo, un grupo pirimidinilo, un grupo piridazinilo, un grupo furanilo, un grupo tienilo, un grupo pirrolilo, un grupo pirazolilo, un grupo imidazolilo, un grupo piranilo (cada uno de dichos grupos fenilo, bifenilo, alfa-naftilo, beta-naftilo, bencilo, piridilo, pirimidinilo, piridazinilo, furanilo, tienilo, pirrolilo, pirazolilo, imidazolilo y piranilo puede estar sustituido con a lo sumo tres grupos hidroxi, alquilo de 1 a 7 átomos de carbono y alcoxi de 1 a 7 átomos de carbono, y un átomo de halogeno); un grupo sililo sustituido, un grupo acilo alifático de 1 a 14 átomos de carbono, un grupo acilo aromático de 6 a 10 átomos de carbono o un grupo -A-B (A es un grupo de hidrocarburo divalente saturado, de 1 a 6 átomos de carbono, o insaturado de 2 a 6 átomos de carbono, que puede estar sustituido con a lo sumo tres grupos hidroxilo, oxo y alquilo de 1 a 7 átomos de carbono; y B es los grupos cicloalquilo de 3 a 10 átomos de carbono, cicloalquenilo de 3 a 7 átomos de carbono, aromático de 6 a 14 átomos de carbono y aromático heterociclico de 4 a 12 átomos de carbono, que pueden tener a lo sumo cinco sustituyentes en total (dicho grupo aromático heterociclico puede contener a lo sumo cinco heteroátomos seleccionados del grupo que consiste de un átomo de oxígeno, un átomo de azufre y un átomo de nitrogeno como constituyentes para el anillo heterociclico); o un grupo heterocicloalifático de 4 a 5 átomos de carbono (dicho grupo heterocicloalifático puede contener a lo sumo tres heteroátomos seleccionados del grupo que consiste de un átomo de oxígeno, un átomo de azufre y un átomo de nitrogeno, como constituyentes para el anillo heterociclico)); cada uno de R1, R2 y R3 es independientemente un átomo de hidrogeno, un grupo alquilo de 1 a 7 átomos de carbono (que puede estar sustituido con un grupo hidroxilo), un grupo cicloalquilo de 3 a 7 átomos de carbono, un grupo hidroxilo o un átomo de halogeno; R4 es un átomo de hidrogeno o un grupo alquilo de 1 a 7 átomos de carbono, o forma junto con R7 una ligadura; y n es 0 o 1).
MX9604430A 1994-03-28 1995-03-27 Tiazolidinas del tipo piridina. MX9604430A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5719294 1994-03-28
JP29517794 1994-11-29
PCT/JP1995/000560 WO1995026347A1 (en) 1994-03-28 1995-03-27 Thiazolidines and oxazolidines substituted by a pyridine ring and their use as hypoglycemic agents

Publications (1)

Publication Number Publication Date
MX9604430A true MX9604430A (es) 1997-12-31

Family

ID=26398213

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9604430A MX9604430A (es) 1994-03-28 1995-03-27 Tiazolidinas del tipo piridina.

Country Status (19)

Country Link
EP (1) EP0751944B1 (es)
KR (1) KR100340615B1 (es)
CN (1) CN1045776C (es)
AT (1) ATE198200T1 (es)
AU (1) AU683739B2 (es)
CA (1) CA2186381A1 (es)
CZ (1) CZ282096A3 (es)
DE (1) DE69519666T2 (es)
DK (1) DK0751944T3 (es)
ES (1) ES2154727T3 (es)
GR (1) GR3035277T3 (es)
HU (1) HUT76062A (es)
IL (1) IL113112A (es)
MX (1) MX9604430A (es)
NZ (1) NZ282893A (es)
PT (1) PT751944E (es)
RU (1) RU2125053C1 (es)
TW (1) TW420669B (es)
WO (1) WO1995026347A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0749430T3 (da) * 1994-03-08 2000-02-07 American Home Prod Thiazolidindion-derivater som antihyperglykæmiske midler
US5889025A (en) * 1996-05-06 1999-03-30 Reddy's Research Foundation Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973848B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
BR9711098B1 (pt) * 1996-07-01 2011-10-04 compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos e seu uso no tratamento de diabetes e doenças relacionadas.
US6114526A (en) * 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6313113B1 (en) * 1997-04-15 2001-11-06 Reddy-Cheminor, Inc. Heterocyclic compounds having antidiabetic, hypolipidemic and antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US6011031A (en) * 1997-05-30 2000-01-04 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension: process for their preparation and pharmaceutical compositions containing them
US6756360B1 (en) 1998-12-24 2004-06-29 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
PT1339678E (pt) 2000-11-27 2007-11-30 Pfizer Prod Inc Agonistas selectivos do receptor ep4 no tratamento de osteoporose
MY148985A (en) * 2006-03-24 2013-06-28 Array Biopharma Inc 2-aminopyridine analogs as glucokinase activators
CN101311167B (zh) * 2007-05-25 2011-04-06 天津药物研究院 1-苯基咪唑烷-2,4-二酮类衍生物及其用途
CN102884062B (zh) 2009-12-23 2016-08-03 嘉世高制药公司 氨基嘧啶激酶抑制剂
AU2012245344B2 (en) 2011-04-22 2017-11-09 Jasco Pharmaceuticals, LLC Aminopyrimidine kinase inhibitors
KR101990605B1 (ko) * 2011-11-04 2019-06-18 자스코 파머수티컬스, 엘엘씨 아미노피리미딘 키나아제 억제제
KR20160004272U (ko) 2015-06-04 2016-12-14 심명보 걸이구가 구비된 케이블행거
KR200488728Y1 (ko) 2017-06-15 2019-03-11 심명보 걸이구가 구비된 케이블행거
EP3658142B1 (en) 2017-07-28 2024-04-17 Applied Therapeutics, Inc. Compositions and methods for treating galactosemia
EP3966320A4 (en) 2019-05-07 2023-10-25 University of Miami TREATMENT AND DETECTION OF HEREDITARY NEUROPATHIES AND ASSOCIATED DISORDERS
KR102433164B1 (ko) * 2020-06-29 2022-08-18 한국전력공사 길이와 각도 조절이 가능한 케이블 행거

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5564586A (en) * 1978-11-09 1980-05-15 Takeda Chem Ind Ltd Thiazolidine derivative
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
JPH065228A (ja) * 1992-06-18 1994-01-14 Mitsubishi Electric Corp 偏向デバイス
TW245716B (es) * 1992-12-28 1995-04-21 Takeda Pharm Industry Co
KR960002625A (ko) * 1994-06-17 1996-01-26 제임스 조셉 드롱 다층 레지스트의 플라즈마 에칭을 위한 방법 및 장치

Also Published As

Publication number Publication date
DK0751944T3 (da) 2001-01-08
IL113112A0 (en) 1995-06-29
KR100340615B1 (ko) 2002-10-18
PT751944E (pt) 2001-03-30
EP0751944B1 (en) 2000-12-20
DE69519666D1 (de) 2001-01-25
WO1995026347A1 (en) 1995-10-05
EP0751944A1 (en) 1997-01-08
CN1144526A (zh) 1997-03-05
TW420669B (en) 2001-02-01
AU2083395A (en) 1995-10-17
KR970701716A (ko) 1997-04-12
HU9602645D0 (en) 1996-11-28
IL113112A (en) 2000-06-01
AU683739B2 (en) 1997-11-20
CZ282096A3 (en) 1997-03-12
NZ282893A (en) 1997-07-27
ES2154727T3 (es) 2001-04-16
CA2186381A1 (en) 1995-10-05
RU2125053C1 (ru) 1999-01-20
HUT76062A (en) 1997-06-30
DE69519666T2 (de) 2001-04-26
ATE198200T1 (de) 2001-01-15
CN1045776C (zh) 1999-10-20
GR3035277T3 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
MX9604430A (es) Tiazolidinas del tipo piridina.
MX9709951A (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
AR240929A2 (es) "n-piridinsulfonil-n'-piridinil-y-triazinil-ureas procedimiento parasu preparacion, intermediarios para uso exclusivo en dicho procedimiento, y composiciones que contienen dichas ureas"
WO2003016291A1 (fr) Activateur du recepteur $g(d) sensible au proliferateur de peroxysome
CA2325741A1 (en) Urea derivatives having tnf- .alpha. production inhibitory effects
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
BG100900A (en) (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
MY111870A (en) Novel antimicrobial quinolone thioureas.
DE69420564D1 (de) Immunsuppressive und antiallergische verbindungen; z.b. n-(3-oxohexanoyl)-homoserinlacton
GR3036017T3 (en) Heterocyclic fungicides
CO4940479A1 (es) Derivados fenil y aminofenil-alquilsulfonamida y de urea
ES468119A1 (es) Un procedimiento para la preparacion de triazinas
ES2124545T3 (es) Azolidindionas como agentes antihiperglucemicos.
GR3006406T3 (es)
GB9408185D0 (en) New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
HUP0203431A2 (hu) Új heterociklusos vegyületek és sóik, és ezeket tartalmazó gyógyszerkészítmények, valamint felhasználásuk
SE8505887L (sv) Indoler
ES8506655A1 (es) Procedimiento para la obtencion de un derivado de fenilsulfonilguanidina
DE69119282D1 (de) Aminobenzolverbindungen, Herstellung und Verwendung
ATE262326T1 (de) 2-adamantanmethanamin verbindungen zur behandlung von abweichungen bei glutamatergischen übertragungen
MX9302388A (es) Oxazolidinonas fungicidas y composicion fungicida que las contiene
ES8303307A1 (es) "un procedimiento para preparar derivados de urea y tiourea".
BR9809768A (pt) Aplicação de sulfoniloxadiazolonas como microbicidas
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
ZA824820B (en) A synergistic composition and a process for selectively combating weeds, especially in cereal crops